Cancer therapy shouldn't come at the cost of #HeartFailure.
This study identifies the miR-144-5p/ACSM1 pathway as a driver of #doxorubicin-related heart injury, revealing a strategy to protect cardiac function during chemotherapy.

Cancer therapy shouldn't come at the cost of #HeartFailure.
This study identifies the miR-144-5p/ACSM1 pathway as a driver of #doxorubicin-related heart injury, revealing a strategy to protect cardiac function during chemotherapy.
Dezrazoxane ejerce un efecto cardioprotector de doxorrubicina sobre la función sistólica ventricular izquierda a largo plazo y puede reducir las necesidades de cribado #dexrazoxane #doxorubicin #cardiac ascopubs.org/doi/abs/10.1...
Localized drug delivery could improve how #chemotherapy reaches tumors.
This study develops porous PCL/PEG/PLA #scaffolds for #doxorubicin delivery, with polymer composition tuning drug loading and sustained release for up to 720 hours.